{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:21:31Z","timestamp":1707524491604},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,26]]},"DOI":"10.7759\/cureus.22638","type":"journal-article","created":{"date-parts":[[2022,2,27]],"date-time":"2022-02-27T04:25:08Z","timestamp":1645935908000},"source":"Crossref","is-referenced-by-count":1,"title":["Biphasic Peritoneal Mesothelioma: A Lethal Clinical Entity"],"prefix":"10.7759","author":[{"given":"Abdul","family":"Waheed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahin","family":"Foroutan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"McCloskey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harmanprit","family":"Randhawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick D","family":"Cason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2021.1955971","article-title":"Epidemiology and outcome of peritoneal and pleural mesothelioma subtypes in Norway. A 20 year nation-wide study","volume":"60","author":"Brustugun OT","year":"2021","unstructured":"Brustugun OT, Nilssen Y, Eide IJ. Epidemiology and outcome of peritoneal and pleural mesothelioma subtypes in Norway. A 20 year nation-wide study. Acta Oncol. 2021, 60:1250-6. 10.1080\/0284186X.2021.1955971","journal-title":"Acta Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-021-03231-4","article-title":"Malignant peritoneal mesothelioma: correlation between CT imaging features and histologic subtypes","volume":"46","author":"Atre ID","year":"2021","unstructured":"Atre ID, Watane GV, Harisinghani MG. Malignant peritoneal mesothelioma: correlation between CT imaging features and histologic subtypes. Abdom Radiol (NY). 2021, 46:5105-13. 10.1007\/s00261-021-03231-4","journal-title":"Abdom Radiol (NY)"},{"key":"ref3","article-title":"Malignant peritoneal mesothelioma -- diagnostic and therapeutic difficulties (Article in Portuguese)","volume":"15","author":"Cunha P","year":"2002","unstructured":"Cunha P, Luz Z, Sees I, et al.. Malignant peritoneal mesothelioma -- diagnostic and therapeutic difficulties (Article in Portuguese). Acta Med Port. 2002, 15:383-6.","journal-title":"Acta Med Port"},{"key":"ref4","article-title":"Peritoneal mesothelioma","volume":"24","author":"Raptopoulos V","year":"1985","unstructured":"Raptopoulos V. Peritoneal mesothelioma. Crit Rev Diagn Imaging. 1985, 24:293-328.","journal-title":"Crit Rev Diagn Imaging"},{"key":"ref5","article-title":"Peritoneal mesothelioma: a review","volume":"9","author":"Bridda A","year":"2007","unstructured":"Bridda A, Padoan I, Mencarelli R, Frego M. Peritoneal mesothelioma: a review. MedGenMed. 2007, 9:32.","journal-title":"MedGenMed"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4103\/IJPM.IJPM_111_20","article-title":"Histological and immunohistochemical characteristics and p16 status studied by FISH in six incidentally detected cases of well-differentiated papillary mesothelioma of the peritoneum","volume":"64","author":"Fujishima F","year":"2021","unstructured":"Fujishima F, Konosu-Fukaya S, Nabeshima K, et al.. Histological and immunohistochemical characteristics and p16 status studied by FISH in six incidentally detected cases of well-differentiated papillary mesothelioma of the peritoneum. Indian J Pathol Microbiol. 2021, 64:277-81. 10.4103\/IJPM.IJPM_111_20","journal-title":"Indian J Pathol Microbiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02248-5","article-title":"Three newly established immortalized mesothelial cell lines exhibit morphological phenotypes corresponding to malignant mesothelioma epithelioid, intermediate, and sarcomatoid types, respectively","volume":"21","author":"Sato T","year":"2021","unstructured":"Sato T, Nakanishi H, Akao K, Okuda M, Mukai S, Kiyono T, Sekido Y. Three newly established immortalized mesothelial cell lines exhibit morphological phenotypes corresponding to malignant mesothelioma epithelioid, intermediate, and sarcomatoid types, respectively. Cancer Cell Int. 2021, 21:546. 10.1186\/s12935-021-02248-5","journal-title":"Cancer Cell Int"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn.441530-20201110-00603","article-title":"Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (Article in Chinese)","volume":"24","author":"Yu Y","year":"2021","unstructured":"Yu Y, Li XB, Lin YL, et al.. Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (Article in Chinese). Zhonghua Wei Chang Wai Ke Za Zhi. 2021, 24:230-9. 10.3760\/cma.j.cn.441530-20201110-00603","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtocrr.2021.100231","article-title":"Phase 2 study of olaparib in malignant mesothelioma and correlation of efficacy with germline or somatic mutations in BAP1 gene","volume":"2","author":"Ghafoor A","year":"2021","unstructured":"Ghafoor A, Mian I, Wagner C, et al.. Phase 2 study of olaparib in malignant mesothelioma and correlation of efficacy with germline or somatic mutations in BAP1 gene. JTO Clin Res Rep. 2021, 2:100231. 10.1016\/j.jtocrr.2021.100231","journal-title":"JTO Clin Res Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2020.1858194","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) with cisplatin in pediatric patients with peritoneal mesothelioma: a single institution experience and long term follow up","volume":"38","author":"Malekzadeh P","year":"2021","unstructured":"Malekzadeh P, Good M, Hughes MS. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) with cisplatin in pediatric patients with peritoneal mesothelioma: a single institution experience and long term follow up. Int J Hyperthermia. 2021, 38:326-31. 10.1080\/02656736.2020.1858194","journal-title":"Int J Hyperthermia"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2021.04.012","article-title":"Concerning CT features predict outcome of treatment in patients with malignant peritoneal mesothelioma","volume":"47","author":"Sugarbaker PH","year":"2021","unstructured":"Sugarbaker PH, Chang D, Jelinek JS. Concerning CT features predict outcome of treatment in patients with malignant peritoneal mesothelioma. Eur J Surg Oncol. 2021, 47:2212-9. 10.1016\/j.ejso.2021.04.012","journal-title":"Eur J Surg Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2017.07.015","article-title":"The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell\/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center","volume":"67","author":"Marchevsky AM","year":"2017","unstructured":"Marchevsky AM, LeStang N, Hiroshima K, et al.. The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell\/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center. Hum Pathol. 2017, 67:160-8. 10.1016\/j.humpath.2017.07.015","journal-title":"Hum Pathol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.12669\/pjms.296.3938","article-title":"Malignant mesothelioma","volume":"29","author":"Ahmed I","year":"2013","unstructured":"Ahmed I, Tipu SA, Ishtiaq S. Malignant mesothelioma. Pak J Med Sci. 2013, 29:1433-8. 10.12669\/pjms.296.3938","journal-title":"Pak J Med Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001574","article-title":"Malignant peritoneal mesothelioma arising in young adults with long-standing indwelling intra-abdominal shunt catheters","volume":"45","author":"Mujahed T","year":"2021","unstructured":"Mujahed T, Tazelaar HD, Sukov WR, et al.. Malignant peritoneal mesothelioma arising in young adults with long-standing indwelling intra-abdominal shunt catheters. Am J Surg Pathol. 2021, 45:255-62. 10.1097\/PAS.0000000000001574","journal-title":"Am J Surg Pathol"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14040942","article-title":"Incidence, survival analysis and future perspective of primary peritoneal mesothelioma (PPM): a population-based study from SEER database","volume":"14","author":"Ullah A","year":"2022","unstructured":"Ullah A, Waheed A, Khan J, et al.. Incidence, survival analysis and future perspective of primary peritoneal mesothelioma (PPM): a population-based study from SEER database. Cancers. 2022, 14:942.","journal-title":"Cancers"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/88256-biphasic-peritoneal-mesothelioma-a-lethal-clinical-entity","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:39:11Z","timestamp":1707507551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/88256-biphasic-peritoneal-mesothelioma-a-lethal-clinical-entity"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,26]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.22638","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,26]]}}}